Levels of plasma myelin-associated proteins and inflammatory factors in patients with major depressive disorder
-
摘要:
目的 比较首发未服药和复发性抑郁症患者外周血浆髓鞘相关蛋白及炎性因子与健康人群的差异。 方法 纳入2019年3月—2020年5月于郑州大学第一附属医院精神医学科就诊的抑郁症患者80例,其中首次发病未服药抑郁症患者40例为首发组,复发抑郁症患者40例为复发组,同期38例健康志愿者为对照组。采用酶联免疫吸附实验测定所有受试者的外周血浆髓鞘碱性蛋白(MBP)、髓鞘相关糖蛋白(MAG)、髓鞘少突胶质细胞糖蛋白(MOG)、C反应蛋白(CRP)、白介素-6(IL-6)和肿瘤坏死因子α(TNF-α)水平。使用汉密尔顿抑郁量表(HAMD-24)评估抑郁程度。 结果 复发组、首发组、对照组的MBP[(2.32±0.95)ng/mL、(1.92±0.91)ng/mL、(1.40±0.76)ng/mL]和TNF-α[(8.49±5.45)ng/mL、(6.30±4.71)ng/mL、(4.90±4.18)ng/mL]组间差异有统计学意义(F=10.824、5.510,均P<0.05);复发组高于首发组(tMBP=4.646,P<0.05;tTNF-α=3.285,P<0.05),复发组高于对照组(tMBP=2.069,P<0.05;tTNF-α=2.034,P<0.05),首发组MBP高于对照组(t=2.603,P<0.05)。髓鞘相关蛋白及炎性因子与HAMD-24评分无相关性(均P>0.05)。 结论 外周血浆的MBP有望作为判断抑郁症预后及神经髓鞘病理损伤严重程度的重要指标,TNF-α可能与抑郁症的复发有关。 Abstract:Objective To compare the levels of peripheral plasma myelin-associated protein and inflammatory factors between patients with first-episode untreated and recurrent major depressive disorder and healthy people. Methods A total of 118 subjects in our hospital from March 2019 to May 2020 were recruited, including 40 patients with first-episode untreated major depressive disorder (first-episode group), 40 patients with recurrent major depressive disorder (recurrent group) and 38 healthy controls (control group). The levels of peripheral plasma myelin basic protein (MBP), myelin-associated glycoprotein, myelin oligodendrocyte glycoprotein, C-reactive protein, interleukin-6 and tumour necrosis factor-α (TNF-α) were measured by enzyme-linked immunosorbent assay. The 24-item Hamilton Depression scale (HAMD-24) was used to score the degree of depression in all patients. Results Statistically significant differences were observed in the levels of MBP amongst the three groups [recurrent group (2.32±0.95) ng/mL; first-episode group (1.92±0.91) ng/mL; control group (1.40±0.76) ng/mL] and TNF-α [recurrent group (8.49±5.45) ng/mL; first-episode group (6.30±4.71) ng/mL; control group (4.90±4.18) ng/mL, FMBP=10.824, P < 0.05; FTNF-α=5.510, P < 0.05]. The levels of MBP and TNF-α in the recurrent group were significantly higher than those in the first-episode group (tMBP=4.646, P < 0.05; tTNF-α=3.285, P < 0.05), whilst the levels of MBP and TNF-α in the recurrent group were significantly higher than those in the control group (tMBP=2.069, P < 0.05; tTNF-α=2.034, P < 0.05). The MBP of the first-episode group was significantly higher than that of the control group (tMBP=2.603, P < 0.05). No significant correlation was observed between the levels of myelin-associated protein, inflammatory factors and HAMD-24 scores. Conclusion The level of MBP in peripheral plasma may be an important biomarker to determine the prognosis of depression and the severity of pathological injury of the nerve myelin sheath. The level of TNF-α may be related to the recurrence of major depressive disorder. -
表 1 3组研究对象一般资料及抑郁程度评分比较
组别 例数 性别(男/女, 例) 年龄(x±s, 岁) 受教育年限(x±s, 年) HAMD-24评分(x±s, 分) MDD首发组 40 19/21 25.20±7.91 11.30±3.13 33.87±8.46 MDD复发组 40 16/24 25.53±7.78 11.08±2.63 37.43±9.43 健康对照组 38 18/20 25.37±7.78 11.92±3.66 统计量 0.591a 0.023b 0.746b -1.772c P值 0.744 0.977 0.476 0.080 注:a为χ2值,b为F值,c为t值。 表 2 3组研究对象髓鞘相关蛋白和炎性因子比较
组别 例数 MBP(x±s, ng/mL) MAG[M(P25, P75), ng/mL] MOG[M(P25, P75), ng/mL] CRP[M(P25, P75), mg/L] IL-6[M(P25, P75), pg/mL] TNF-α(x±s, pg/mL) MDD首发组 40 1.92±0.91a 0.11(0.06, 0.21) 92.81(60.62,141.20)a 1.52(0.89, 1.64) 7.02(1.81,11.71) 6.30±4.71 MDD复发组 40 2.32±0.95ab 0.14(0.10, 0.32) 103.57(73.53,159.92)a 2.18(0.90, 2.41)a 7.16(3.00,18.63) 8.49±5.45ab 健康对照组 38 1.40±0.76 0.13(0.08, 0.16) 68.51(41.84,90.10) 1.13(0.83, 1.06) 4.32(1.85,10.36) 4.90±4.18 统计量 10.824c 5.115d 15.937d 13.979d 5.157d 5.510c P值 < 0.001 0.077 < 0.001 0.001 0.076 0.005 注:与健康对照组比较,aP < 0.05;与MDD首发组比较,bP < 0.05。c为F值,d为H值。 表 3 髓鞘相关蛋白、炎性因子与HAMD-24评分的相关性(r值)
组别 MBP MAG MOG CRP IL-6 TNF-α MDD首发组 0.130 0.062 0.118 0.014 0.039 0.204 MDD复发组 0.189 0.216 0.070 0.190 0.299 0.026 注:均P>0.05。 -
[1] DADI A F, MILLER E R, BISETEAN T A, et al. Global burden of antenatal depression and its association with adverse birth outcomes: An umbrella review[J]. BMC Public Health, 2020, 20(1): 173. doi: 10.1186/s12889-020-8293-9 [2] MALHI G, MANN J. Depression[J]. The Lancet, 2018, 392(10161): 2299-2312. doi: 10.1016/S0140-6736(18)31948-2 [3] NOBIS A, ZALEWSKI D, WASZKIEWICZ N. Peripheral markers of depression[J]. J Clin Med, 2020, 9: 3793. doi: 10.3390/jcm9123793 [4] BYRNE M L, WHITTLE S, ALLEN N B. The role of brain structure and function in the association between inflammation and depressive symptoms: A systematic review[J]. Psychosom Med, 2016, 78(4): 389-400. doi: 10.1097/PSY.0000000000000311 [5] SHIMIZU T, OSANAI Y, IKENAKA K. Oligodendrocyte-neuron interactions: Impact on myelination and brain function[J]. Neurochem Res, 2018, 43(1): 190-194. doi: 10.1007/s11064-017-2387-5 [6] BODA E. Myelin and oligodendrocyte lineage cell dysfunctions: New players in the etiology and treatment of depression and stress-related disorders[J]. Eur J Neurosci, 2021, 53(1): 281-297. doi: 10.1111/ejn.14621 [7] 张作记. 行为医学量表手册[M]. 北京: 中华医学电子音像出版社, 2001: 225-227, 285-287. [8] 张瀚迪, 方泽漫, 吴彩茹, 等. 慢性不可预测应激对铜腙诱导的小鼠脱髓鞘损伤及抑郁样行为的影响[J]. 中华行为医学与脑科学杂志, 2016, 25(10): 871-876. doi: 10.3760/cma.j.issn.1674-6554.2016.10.002 [9] WILLIAMS L M. Precision psychiatry: A neural circuit taxonomy for depression and anxiety[J]. Lancet Psychiatry, 2016, 3(5): 472-480. doi: 10.1016/S2215-0366(15)00579-9 [10] LU Y, ZHOU S, FAN C X, et al. Higher inflammation and cerebral white matter injury associated with cognitive deficit in asthmatic patients with depression[J]. J Asthma, 2020. DOI: 10.1080/02770903.2020.1853155. [11] 吴玉华, 王晓红, 王蒙, 等. 少突胶质细胞、髓鞘碱性蛋白与抑郁症的相关性研究进展[J]. 神经疾病与精神卫生, 2016, 16(6): 732-734. doi: 10.3969/j.issn.1009-6574.2016.06.029 [12] 张珊, 赵静洁, 李丽. 免疫炎症与抑郁症[J]. 中华行为医学与脑科学杂志, 2019, 28(7): 660-665. doi: 10.3760/cma.j.issn.1674-6554.2019.07.017 [13] CASSIERS L L M, NIEMEGEERS P, FRANSEN E, et al. Neuroendocrine and inflammatory effects of childhood trauma following psychosocial and inflammatory stress in women with remitted major depressive disorder[J]. Brain Sci, 2019, 9(12): 375. doi: 10.3390/brainsci9120375 [14] CASSANO P, BUI E, ROGERS A H, et al. Inflammatory cytokines in major depressive disorder: A case-control study[J]. Aust N Z J Psychiatry, 2017, 51(1): 23-31. doi: 10.1177/0004867416652736 [15] CARVALHO A F, SOLMI M, SANCHES M, et al. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders[J]. Transl Psychiatry, 2020, 10(1): 152. http://diposit.ub.edu/dspace/bitstream/2445/174163/1/700808.pdf [16] LIU J J, WEI Y B, STRAWBRIDGE R, et al. Peripheral cytokine levels and response to antidepressant treatment in depression: A systematic review and meta-analysis[J]. Mol Psychiatry, 2020, 25(2): 339-350. doi: 10.1038/s41380-019-0474-5 [17] MILLER E S, SAKOWICZ A, ROY A, et al. Plasma and cerebrospinal fluid inflammatory cytokines in perinatal depression[J]. Am J Obstet Gynecol, 2019, 220(3): 271. e1-271. e10. doi: 10.1016/j.ajog.2018.12.015 [18] 刘敏, 杜巧荣, 王禹辰, 等. 抑郁症患者人格、应对方式和抑郁严重程度的关系[J]. 中国健康心理学杂志, 2020, 28(6): 801-805. https://www.cnki.com.cn/Article/CJFDTOTAL-JKXL202006001.htm [19] 谢军, 耿峰, 董毅, 等. 抑郁症患者童年期虐待与自我病耻感水平的相关性研究[J]. 中华全科医学, 2019, 17(7): 1171-1173. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201907032.htm -

计量
- 文章访问数: 404
- HTML全文浏览量: 156
- PDF下载量: 3
- 被引次数: 0